Today we are watching…
1. Apple (#aapl)
Apple wants to sell you a cheese grater for $6000, but it’s not just any cheese grater! The Cupertino tech giant, famed for keeping its gadgetry designs sleek, has given the Mac a makeover. The tower PC no longer looks like a cylindrical trash can, now with a largely minimalist but semi-grated side panel on its polished bodywork. However, the changes to the Mac Pro are not only external. On the inside, the computer has a state-of-the-art 28-core Intel processor and 1.5 TB of memory. In case you’re not a tech geek, that’s a lot of memory! The Mac Pro will be built in Texas after CEO Tim Cook won himself trade war protection from Trump. All investors need now is for customers to start showing up to pay $6000 plus $999 for a stand!
2. Sanofi (#snofi)
Buyout fever in biotech shows no sign of slowing down! The latest firm to play ball is Sanofi, a French pharmaceutical company. It’s decided to target Synthorx and its batch of potential cancer treatments, and despite not being tested for clinical efficiency, they ain’t coming cheap. Synthorx’s share price was $25 on Friday. However, with a little bit of merger magic, a Sanofi $68 bid spelled a 176% premium! Synthorx shares went through the roof, but the madness doesn’t end there! Merck, a known pharmaceutical giant and not one to be overcome, chipped in yesterday with an acquisition of ArQule. Merck’s $20 per share was at a 107% premium. Will this all end in disaster? Or are critical investors just behind the times?